268 related articles for article (PubMed ID: 11056417)
21. Acetylcysteine: a drug that is much more than a mucokinetic.
Ziment I
Biomed Pharmacother; 1988; 42(8):513-9. PubMed ID: 3066412
[TBL] [Abstract][Full Text] [Related]
22. [Mucolytics in acute and chronic respiratory tract disorders. II. Uses for treatment and antioxidant properties].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):248-52. PubMed ID: 12053601
[TBL] [Abstract][Full Text] [Related]
23. The effect of N-acetylcysteine on ifosfamide-induced nephrotoxicity: in vitro studies in renal tubular cells.
Chen N; Aleksa K; Woodland C; Rieder M; Koren G
Transl Res; 2007 Jul; 150(1):51-7. PubMed ID: 17585863
[TBL] [Abstract][Full Text] [Related]
24. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress.
Raghu G; Berk M; Campochiaro PA; Jaeschke H; Marenzi G; Richeldi L; Wen FQ; Nicoletti F; Calverley PMA
Curr Neuropharmacol; 2021; 19(8):1202-1224. PubMed ID: 33380301
[TBL] [Abstract][Full Text] [Related]
25. Ellagic acid, a natural polyphenol protects rat peripheral blood lymphocytes against nicotine-induced cellular and DNA damage in vitro: with the comparison of N-acetylcysteine.
Sudheer AR; Muthukumaran S; Devipriya N; Menon VP
Toxicology; 2007 Jan; 230(1):11-21. PubMed ID: 17188416
[TBL] [Abstract][Full Text] [Related]
26. N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease.
Sadowska AM
Ther Adv Respir Dis; 2012 Jun; 6(3):127-35. PubMed ID: 22361928
[TBL] [Abstract][Full Text] [Related]
27. Effects of N-acetylcysteine on alcohol abstinence and alcohol-induced adverse effects in rats.
Ferreira Seiva FR; Amauchi JF; Ribeiro Rocha KK; Souza GA; Ebaid GX; Burneiko RM; Novelli EL
Alcohol; 2009 Mar; 43(2):127-35. PubMed ID: 19251114
[TBL] [Abstract][Full Text] [Related]
28. [Mucolytics in acute and chronic respiratory tract disorders. I. Pathophysiology and mechanisms of action].
Kupczyk M; Kuna P
Pol Merkur Lekarski; 2002 Mar; 12(69):245-7. PubMed ID: 12053600
[TBL] [Abstract][Full Text] [Related]
29. Multifaceted activity of N-acetyl-l-cysteine in chronic obstructive pulmonary disease.
Calzetta L; Matera MG; Rogliani P; Cazzola M
Expert Rev Respir Med; 2018 Aug; 12(8):693-708. PubMed ID: 29972340
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of ferulic acid on nicotine-induced DNA damage and cellular changes in cultured rat peripheral blood lymphocytes: a comparison with N-acetylcysteine.
Sudheer AR; Muthukumaran S; Kalpana C; Srinivasan M; Menon VP
Toxicol In Vitro; 2007 Jun; 21(4):576-85. PubMed ID: 17222527
[TBL] [Abstract][Full Text] [Related]
31. Acute acetaminophen overdose is associated with dose-dependent hypokalaemia: a prospective study of 331 patients.
Waring WS; Stephen AF; Malkowska AM; Robinson OD
Basic Clin Pharmacol Toxicol; 2008 Mar; 102(3):325-8. PubMed ID: 18047475
[TBL] [Abstract][Full Text] [Related]
32. Distribution of radio-labeled N-Acetyl-L-Cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage.
Arfsten DP; Johnson EW; Wilfong ER; Jung AE; Bobb AJ
Cutan Ocul Toxicol; 2007; 26(2):113-34. PubMed ID: 17612979
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and mechanisms of anaphylactoid reactions to acetylcysteine in acetaminophen overdose.
Pakravan N; Waring WS; Sharma S; Ludlam C; Megson I; Bateman DN
Clin Toxicol (Phila); 2008 Sep; 46(8):697-702. PubMed ID: 18803085
[TBL] [Abstract][Full Text] [Related]
34. [Without liver transplantation paracetamol intoxication is often be lethal, in spite of N-acetylcysteine therapy].
Koivusalo AM; Isoniemi H; Vakkuri A; Höckerstedt K; Nuutinen H
Duodecim; 2002; 118(6):649-50. PubMed ID: 12233010
[No Abstract] [Full Text] [Related]
35. Long-term administration of N-acetylcysteine decreases hydrogen peroxide exhalation in subjects with chronic obstructive pulmonary disease.
Kasielski M; Nowak D
Respir Med; 2001 Jun; 95(6):448-56. PubMed ID: 11421501
[TBL] [Abstract][Full Text] [Related]
36. [Primary results with a new mucolytic agent: N-acetyl-L-cysteine].
da Costa PD; Cardoso PF; Simão AT
Hospital (Rio J); 1965 Aug; 68(2):435-41. PubMed ID: 5295132
[No Abstract] [Full Text] [Related]
37. Clinicopathologic evaluation N-acetylcysteine therapy in acetaminophen toxicosis in the cat.
Gaunt SD; Baker DC; Green RA
Am J Vet Res; 1981 Nov; 42(11):1982-4. PubMed ID: 7337295
[TBL] [Abstract][Full Text] [Related]
38. Acetaminophen poisoning and the use of intravenous N-acetylcysteine.
Clark J
Air Med J; 2001; 20(4):16-7. PubMed ID: 11438806
[TBL] [Abstract][Full Text] [Related]
39. [About paracetamol again].
Hazai E; Monostory K; Bakos A; Zacher G; Vereczkey L
Orv Hetil; 2001 Feb; 142(7):345-9. PubMed ID: 11243017
[TBL] [Abstract][Full Text] [Related]
40. Effects of N-acetylcysteine on the lung histopathology and oxidant-antioxidant status in rabbits exposed to cigarette smoke.
Sezer M; Fidan F; Unlü M; Sahin O; Esme H; Köken T
Tuberk Toraks; 2006; 54(2):144-51. PubMed ID: 16924570
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
